期刊
EXPERIMENTAL DERMATOLOGY
卷 31, 期 10, 页码 1466-1476出版社
WILEY
DOI: 10.1111/exd.14653
关键词
dual-specificity; DUSP3; melanoma; nevi; oncogene; oncogenesis; oncosuppressor; phosphatase; VHR
类别
资金
- A.G. Leventis Foundation
This review focuses on the role of dual-specificity phosphatase 3 (DUSP3) in benign or malignant melanocytic oncogenesis, summarizing the current knowledge and discussing its potential research foundation in tumor development, evolution, management, and therapeutics.
Dual-specificity phosphatase 3 (DUSP3), also known as Vaccinia H1-related phosphatase, is a protein tyrosine phosphatase that typically performs its major role in the regulation of multiple cellular functions through the dephosphorylation of its diverse and constantly expanding range of substrates. Many of the substrates described so far as well as alterations in the expression or the activity of DUSP3 itself are associated with the development and progression of various types of neoplasms, indicating that DUSP3 may be an important player in oncogenesis and a promising therapeutic target. This review focuses exclusively on DUSP3's contribution to either benign or malignant melanocytic oncogenesis, as many of the established culprit pathways and mechanisms constitute DUSP3's regulatory targets, attempting to synthesize the current knowledge on the matter. The spectrum of the DUSP3 interactions analysed in this review covers substrates implicated in cellular growth, cell cycle, proliferation, survival, apoptosis, genomic stability/repair, adhesion and migration of tumor melanocytes. Furthermore, the speculations raised, based on the evidence to date, may be considered a fundament for potential research regarding the oncogenesis, evolution, management and therapeutics of melanocytic tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据